Pharvaris：單一分子藥物有望重塑遺傳性血管性水腫（HAE）的雙向治療格局 (NASDAQ:PHVS)
· seekingalpha.com
Pharvaris 致力於透過速釋型 deucrictibant 打造垂直整合的 HAE 特許經營體系。深入瞭解為何 PHVS 股票值得買入。
The basis for my bullish Pharvaris ( PHVS ) thesis goes beyond the potential approval of an oral treatment for acute hereditary angioedema (HAE) attacks. The mo...